I'm LongbridgeAI, I can summarize articles.Xanadu reported a Q2 FY26 GAAP net loss of $42.1 million, widening from $20.6 million in Q1, while revenue dropped to $1.5 million from $2.8 million. R&D expenses rose to $19.7 million due to engineering hires, and capital expenditures increased to $6.4 million. The company raised $67.2 million through a synthetic at-the-market facility, selling 5.5 million shares at an average net price of $12.28, leaving cash equivalents at $312.8 million.
- Xanadu posted a GAAP net loss of USD 42.1 million in Q2 2026, widening from a loss of USD 20.6 million in Q1 2026. * Revenue fell to USD 1.5 million from USD 2.8 million in Q1 2026; year-over-year increase was primarily driven by DARPA Stage B revenue. * GAAP R&D expense rose to USD 19.7 million from Q1 2026, reflecting higher spending on engineering hires. * GAAP capital expenditures climbed to USD 6.4 million from USD 0.3 million in Q1 2026; cash and cash equivalents totaled USD 312.8 million. * Raised USD 67.2 million via a Yorkville synthetic at-the-market facility, selling 5,500,000 shares at an average net price of USD 12.28. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xanadu Quantum Technologies Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608051605PRIMZONEFULLFEED9804368) on August 05, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)